Anne Wojcicki has been shortlisted for a 2024 Global Recognition Award.

First name

Anne

Last name

Wojcicki

Industry

Biotechnology

Area of excellence

Innovation

Scale of impact or excellence in your field

International

Novelty and originality of innovation

5

Market impact or potential

5

Technological advancement

5

Addressing global challenges

5

Patent portfolio and intellectual property

5

Adoption rate and user feedback

5

Disruption of existing paradigms

5

Scale of impact or excellence in your field

5

Supporting evidence to showcase achievements

I have a background in biology and investment. I started 23andMe to make genetic testing accessible and affordable for everyone. Our direct-to-consumer model empowers individuals with insights into their genetic makeup, impacting personal health decisions and ancestry exploration.

23andMe has driven partnerships with major healthcare organizations to expand genetic research. We prioritize fostering innovation, we continue to enhance our understanding of genetics and its role in personalized medicine.